| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |